Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | decreases expression | EXP | | 6480464 | Ethinyl Estradiol results in decreased expression of MYL12B mRNA | CTD | PMID:29097150 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of MYL12B mRNA | CTD | PMID:20068009 | 17beta-estradiol | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYL12B mRNA | CTD | PMID:20823114 | 17beta-estradiol | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Estradiol results in decreased expression of MYL12B mRNA | CTD | PMID:23019147 | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Myl12b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MYL12B mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MYL12B mRNA | CTD | PMID:34747641 | 2,4,6-tribromophenol | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of MYL12B protein | CTD | PMID:31675489 | 3H-1,2-dithiole-3-thione | decreases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of MYL12B mRNA | CTD | PMID:19162173 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MYL12B mRNA | CTD | PMID:30047161 | aflatoxin B1 | increases methylation | ISO | MYL12B (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MYL12B gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Tretinoin results in increased expression of MYL12B mRNA | CTD | PMID:33167477 | amiloride | decreases phosphorylation | ISO | MYL12B (Homo sapiens) | 6480464 | Amiloride results in decreased phosphorylation of MRLC2 protein | CTD | PMID:11078707 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of MYL12B mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MYL12B mRNA | CTD | PMID:33212167 | benzo[a]pyrene | increases expression | ISO | Myl12b (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of MYL12B mRNA | CTD | PMID:22228805 | bis(2-ethylhexyl) phthalate | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of MYL12B mRNA | CTD | PMID:31163220 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MYL12B mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | bisphenol A results in increased expression of MYL12B protein | CTD | PMID:37567409 | bisphenol A | decreases expression | ISO | Myl12b (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MYL12B mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | ISO | MYL12B (Homo sapiens) | 6480464 | bisphenol A affects the expression of MYL12B mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of MYL12B mRNA and bisphenol A results in decreased expression of MYL12B protein | CTD | PMID:29275510 and PMID:31675489 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MYL12B mRNA | CTD | PMID:29097150 | bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of MYL12B protein | CTD | PMID:25933445 | bucladesine | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYL12B mRNA | CTD | PMID:20823114 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of MYL12B mRNA | CTD | PMID:33453195 | cannabidiol | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [Cannabidiol co-treated with moringin] results in increased expression of MYL12B mRNA | CTD | PMID:30096889 | carbon nanotube | decreases expression | ISO | Myl12b (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | chloropicrin | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | chloropicrin results in increased expression of MRLC2 mRNA | CTD | PMID:26352163 | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of MYL12B protein | CTD | PMID:16470657 | copper atom | multiple interactions | ISO | Myl12b (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MYL12B mRNA | CTD | PMID:15467011 | copper(0) | multiple interactions | ISO | Myl12b (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of MYL12B mRNA | CTD | PMID:15467011 | cyclosporin A | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of MYL12B mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of MYL12B protein | CTD | PMID:31675489 | dicrotophos | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of MYL12B mRNA | CTD | PMID:28302478 | disodium selenite | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of MRLC2 mRNA | CTD | PMID:18175754 | diuron | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Diuron results in decreased expression of MYL12B mRNA | CTD | PMID:35967413 | dorsomorphin | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYL12B mRNA | CTD | PMID:27188386 | doxorubicin | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of MYL12B mRNA | CTD | PMID:29803840 | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of MYL12B mRNA | CTD | PMID:29391264 | ethanol | increases expression | ISO | Myl12b (Mus musculus) | 6480464 | Ethanol results in increased expression of MYL12B mRNA | CTD | PMID:30319688 | fluoranthene | multiple interactions | ISO | Myl12b (Mus musculus) | 6480464 | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of MYL12B mRNA | CTD | PMID:28329830 | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of MYL12B mRNA | CTD | PMID:24136188 | folic acid | affects expression | ISO | Myl12b (Mus musculus) | 6480464 | Folic Acid affects the expression of MYL12B mRNA | CTD | PMID:25629700 | genistein | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | ESR1 promotes the reaction [Genistein results in increased expression of MYL12B protein] | CTD | PMID:20884965 | genistein | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Genistein results in increased expression of MYL12B protein | CTD | PMID:20884965 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of MYL12B mRNA | CTD | PMID:22061828 | hyaluronic acid | decreases expression | EXP | | 6480464 | Hyaluronic Acid analog results in decreased expression of MYL12B protein | CTD | PMID:23178681 | hyaluronic acid | multiple interactions | EXP | | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of MYL12B protein] | CTD | PMID:23178681 | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of MYL12B protein | CTD | PMID:23178681 | hydrogen peroxide | multiple interactions | EXP | | 6480464 | Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of MYL12B protein] | CTD | PMID:23178681 | medroxyprogesterone acetate | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of MYL12B mRNA | CTD | PMID:20823114 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of MYL12B mRNA | CTD | PMID:30047161 | methotrexate | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Methotrexate results in increased expression of MYL12B mRNA | CTD | PMID:21678067 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | Myl12b (Mus musculus) | 6480464 | [MYBPC3 protein affects the susceptibility to benzyloxycarbonylleucyl-leucyl-leucine aldehyde] which results in decreased expression of MYL12B mRNA | CTD | PMID:25566086 | paracetamol | decreases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MYL12B mRNA | CTD | PMID:29067470 | phenylmercury acetate | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of MYL12B mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYL12B mRNA | CTD | PMID:27188386 | resveratrol | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of MYL12B mRNA | CTD | PMID:23557933 | SB 431542 | multiple interactions | ISO | MYL12B (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYL12B mRNA | CTD | PMID:27188386 | sodium arsenate | increases expression | ISO | Myl12b (Mus musculus) | 6480464 | sodium arsenate results in increased expression of MYL12B mRNA | CTD | PMID:30953684 | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of MYL12B mRNA | CTD | PMID:19281266 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of MYL12B mRNA | CTD | PMID:30047161 | tetrachloromethane | affects expression | ISO | Myl12b (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of MYL12B mRNA | CTD | PMID:31919559 | thapsigargin | decreases expression | ISO | Myl12b (Mus musculus) | 6480464 | Thapsigargin results in decreased expression of MYL12B protein | CTD | PMID:24648495 | thapsigargin | decreases expression | EXP | | 6480464 | Thapsigargin results in decreased expression of MYL12B protein | CTD | PMID:35544339 | titanium dioxide | decreases expression | ISO | Myl12b (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of MYL12B mRNA | CTD | PMID:23557971 | tremolite asbestos | decreases expression | ISO | Myl12b (Mus musculus) | 6480464 | tremolite results in decreased expression of MYL12B mRNA | CTD | PMID:29279043 | triadimefon | increases expression | EXP | | 6480464 | triadimefon results in increased expression of MYL12B mRNA | CTD | PMID:30047161 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of MYL12B mRNA | CTD | PMID:33387578 | valproic acid | increases expression | ISO | MYL12B (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MYL12B mRNA | CTD | PMID:23179753 and PMID:28001369 | valproic acid | decreases methylation | ISO | MYL12B (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of MYL12B gene | CTD | PMID:29154799 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of MYL12B mRNA | CTD | PMID:22570695 | |